Table 1. MS evidence of... | American Society of Hematology

Table 1.

MS evidence of HLA-A*02:ALNEQIARL in cell lines and primary tissue samples

Tumor type	Cell line	Primary tissue	References
Hematologic malignancies
AML	AML14, OCI-AML02, THP-1	Yes	39; authors’ own data for cell lines and primary samples
B-ALL	JY, BV173, Nalm6, ALL-3	Yes	40-42
Multiple myeloma	U266	NT	Authors’ own data
DLBCL	DB, SUDHL4	NT	Authors’ own data
T-cell lymphoma	MAC2A	NT	Authors’ own data
MCL	—	Yes	43
Nonhematologic malignancies
Melanoma	A375, SKMEL5 MEWO, MEL624	Yes	44-47
Breast cancer	MDA-MB231	Yes	48; authors’ own data for cells and primary tissue
Colon cancer	—	Yes	29
Prostate cancer	LnCAP	NT	Authors’ own data
Pancreatic cancer	PANC-1	NT	Authors’ own data
Thyroid cancer	TPC-1	NT	Authors’ own data
Mesothelioma	JMN, MESO37	NT	Authors’ own data
Glioblastoma	—	Yes	49

Tumor type	Cell line	Primary tissue	References
Hematologic malignancies
AML	AML14, OCI-AML02, THP-1	Yes	39; authors’ own data for cell lines and primary samples
B-ALL	JY, BV173, Nalm6, ALL-3	Yes	40-42
Multiple myeloma	U266	NT	Authors’ own data
DLBCL	DB, SUDHL4	NT	Authors’ own data
T-cell lymphoma	MAC2A	NT	Authors’ own data
MCL	—	Yes	43
Nonhematologic malignancies
Melanoma	A375, SKMEL5 MEWO, MEL624	Yes	44-47
Breast cancer	MDA-MB231	Yes	48; authors’ own data for cells and primary tissue
Colon cancer	—	Yes	29
Prostate cancer	LnCAP	NT	Authors’ own data
Pancreatic cancer	PANC-1	NT	Authors’ own data
Thyroid cancer	TPC-1	NT	Authors’ own data
Mesothelioma	JMN, MESO37	NT	Authors’ own data
Glioblastoma	—	Yes	49

B-ALL, B-cell acute lymphoblastic leukemia; DLBCL, diffuse large B-cell lymphoma; MCL, myeloid cell leukemia; NT, not tested.